Forschungsprojekte
Ergebnisse pro Seite:
10
2018 - 2023
Exploring DNA methylation/gene silencing patterns in MDS/AML for potential therapeutic Targets- Dr. BorhaneGuezguez
2017 - 2019
AG-221 bei fortgeschrittener AML mit IDH2 Mutation in älteren Patienten (#623)- Prof. Dr. MarkusRadsak
2017
PI3Kδ isoform in TREM-1 mediated neutrophil inflammatory responses (IUFF Stufe 1)- Dr. AstridHasibeder
2017 - 2021
Proteine auf Nanocarriern: vom Stealth Effekt zu einem gezielten Targeting in vivo- Univ.-Prof. Dr. StefanTenzer,
- Prof. Dr. TanjaWeil,
- Prof. Dr. VolkerMailänder
2017 - 2019
Impact of mutational pathways on immune environment, neoantigens and tumor rejection for the development of comprehensive biomarker panels in cancer immunotherapy- Prof. Dr. AngelaKrackhardt,
- Prof. Dr. StefanFröhling,
- Prof. Dr. WilkoWeichert,
- Prof. Dr. HannoGlimm,
- Prof. Dr. BenediktBrors,
- Prof. Dr. PeterSchirmacher,
- Dr. FelixLasitschka,
- Dr. AlbrechtStenziger,
- Prof. Dr. RolandRad,
- Prof. Dr. KarstenSpiekermann,
- Prof. Dr. MarionSubklewe,
- Prof. Dr. ChristianBrandts,
- PD Dr. ThomasKindler,
- Prof. Dr. FlorianGreten,
- Univ.-Prof. Dr. ThomasWölfel,
- Univ.-Prof. Dr. MatthiasTheobald,
- Dr. HakimEchchannaoui,
- Prof. Dr. SebastianBauer,
- JensSiveke,
- Prof. Dr. Nikolasvon Bubnoff,
- Dr. MelanieBörries,
- Prof. Dr. SilkeLassmann,
- Dr. StefanHaug,
- Prof. Dr. MartinWerner,
- PD Dr. GunnarFolprecht,
- Prof. Dr. EvelinSchrock,
- Dr. BarbaraKlink,
- PD Dr. AnneLetsch,
- PD Dr. SebastianOchsenreither,
- PD Dr. FrederickKlauschen,
- Prof. Dr. MatthiasMann,
- Prof. Dr. JürgenCox
2017 - 2019
Chimeric antigen receptor-engineered natural killer cells as a universal cellular therapeutic for adoptive cancer immunotherapy (collaborative research project within translational immunotherapy program)- Prof. Dr. WinfriedWels,
- Univ.-Prof. Dr. MatthiasTheobald,
- Prof. Dr. MichaelBachmann,
- Prof. Dr. AchimTemme,
- Prof. Dr. TorstenTonn,
- Prof. Dr. DirkJäger,
- PD Dr. JessicaHassel,
- Prof. Dr. JürgenBecker,
- PD Dr. AnnettePaschen